Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001027796-25-000049
Filing Date
2025-10-14
Accepted
2025-10-14 16:50:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5354
  Complete submission text file 0001027796-25-000049.txt   7108
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Subject) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-55565 | Film No.: 251392394
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 320 PARK AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address 320 PARK AVENUE, 8TH FLOOR NEW YORK NY 10022 212-355-1600
PZENA INVESTMENT MANAGEMENT LLC (Filed by) CIK: 0001027796 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A